These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 7483727

  • 21. Evidence for neurological dysfunction in end-stage protoporphyric liver disease.
    Rank JM, Carithers R, Bloomer J.
    Hepatology; 1993 Dec; 18(6):1404-9. PubMed ID: 8244265
    [Abstract] [Full Text] [Related]

  • 22. [Often unrecognized: erythropoietic protoporphyria].
    Minder EI, Schneider-Yin X.
    Schweiz Med Wochenschr; 1993 Feb 13; 123(6):229-33. PubMed ID: 8434252
    [Abstract] [Full Text] [Related]

  • 23. Hepatic failure and death from erythropoietic protoporphyria.
    Singer JA, Plaut AG, Kaplan MM.
    Gastroenterology; 1978 Mar 13; 74(3):588-91. PubMed ID: 631490
    [Abstract] [Full Text] [Related]

  • 24. Erythropoietic protoporphyria terminating in liver failure.
    Romslo I, Gadeholt HG, Høvding G.
    Arch Dermatol; 1982 Sep 13; 118(9):668-71. PubMed ID: 7114870
    [Abstract] [Full Text] [Related]

  • 25. Biochemical abnormality in erythropoietic protoporphyria: cause and consequences.
    Bloomer JR, Wang Y, Singhal A, Risheg H.
    J Pediatr Gastroenterol Nutr; 2006 Jul 13; 43 Suppl 1():S36-40. PubMed ID: 16819399
    [Abstract] [Full Text] [Related]

  • 26. Ferrochelatase gene mutations in erythropoietic protoporphyria: focus on liver disease.
    Chen FP, Risheg H, Liu Y, Bloomer J.
    Cell Mol Biol (Noisy-le-grand); 2002 Feb 13; 48(1):83-9. PubMed ID: 11929052
    [Abstract] [Full Text] [Related]

  • 27. A mouse model provides evidence that genetic background modulates anemia and liver injury in erythropoietic protoporphyria.
    Abitbol M, Bernex F, Puy H, Jouault H, Deybach JC, Guénet JL, Montagutelli X.
    Am J Physiol Gastrointest Liver Physiol; 2005 Jun 13; 288(6):G1208-16. PubMed ID: 15677551
    [Abstract] [Full Text] [Related]

  • 28. Liver transplantation for erythropoietic protoporphyria. Report of a new case with subsequent medium-term follow-up.
    Mion FB, Faure JL, Berger F, McGregor B, Perrot H, Paliard P.
    J Hepatol; 1992 Sep 13; 16(1-2):203-7. PubMed ID: 1484154
    [Abstract] [Full Text] [Related]

  • 29. Erythropoietic protoporphyria and early onset of cholestasis.
    Khalili MJ, Farahmand F, Hirbod-Mobarakeh A, Yousefi A, Sotoudeh S, Monajemzadeh M, Razaghian A, Rezaei N.
    Turk J Pediatr; 2012 Sep 13; 54(6):645-50. PubMed ID: 23692792
    [Abstract] [Full Text] [Related]

  • 30. Stimulation of fecal fat excretion and the disposal of protoporphyrin in a murine model for erythropoietic protoporphyria.
    Gooijert KE, Havinga R, Oosterloo-Duinkerken AR, Venekamp-Hoolsema EE, Kuipers F, Verkade HJ.
    Am J Physiol Gastrointest Liver Physiol; 2007 Aug 13; 293(2):G510-6. PubMed ID: 17600043
    [Abstract] [Full Text] [Related]

  • 31. Liver transplantation for erythropoietic protoporphyria liver disease.
    McGuire BM, Bonkovsky HL, Carithers RL, Chung RT, Goldstein LI, Lake JR, Lok AS, Potter CJ, Rand E, Voigt MD, Davis PR, Bloomer JR.
    Liver Transpl; 2005 Dec 13; 11(12):1590-6. PubMed ID: 16315313
    [Abstract] [Full Text] [Related]

  • 32. Prevention of murine erythropoietic protoporphyria-associated skin photosensitivity and liver disease by dermal and hepatic ferrochelatase.
    Pawliuk R, Tighe R, Wise RJ, Mathews-Roth MM, Leboulch P.
    J Invest Dermatol; 2005 Jan 13; 124(1):256-62. PubMed ID: 15654982
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Cholestyramine resin for erythropoietic protoporphyria with severe hepatic disease: a case report.
    Yoo DJ, Lee HC, Yu E, Jin YJ, Shim JH, Kim KM, Lim YS, Chung YH, Lee YS, Suh DJ.
    Korean J Hepatol; 2010 Mar 13; 16(1):83-8. PubMed ID: 20375647
    [Abstract] [Full Text] [Related]

  • 36. Liver failure in erythropoietic protoporphyria associated with choledocholithiasis and severe post-transplantation polyneuropathy.
    Lock G, Holstege A, Mueller AR, Christe W, Doss MO, Schölmerich J, Neuhaus P.
    Liver; 1996 Jun 13; 16(3):211-7. PubMed ID: 8873010
    [Abstract] [Full Text] [Related]

  • 37. Red blood cell exchange transfusion in two patients with advanced erythropoietic protoporphyria.
    Eichbaum QG, Dzik WH, Chung RT, Szczepiorkowski ZM.
    Transfusion; 2005 Feb 13; 45(2):208-13. PubMed ID: 15660829
    [Abstract] [Full Text] [Related]

  • 38. Porphyrins, porphyrin metabolism and porphyrias. IV. Pathophysiology of erythyropoietic protoporphyria--diagnosis, care and monitoring of the patient.
    Thunell S, Harper P, Brun A.
    Scand J Clin Lab Invest; 2000 Nov 13; 60(7):581-604. PubMed ID: 11202051
    [Abstract] [Full Text] [Related]

  • 39. The value of intravenous heme-albumin and plasmapheresis in reducing postoperative complications of orthotopic liver transplantation for erythropoietic protoporphyria.
    Reichheld JH, Katz E, Banner BF, Szymanski IO, Saltzman JR, Bonkovsky HL.
    Transplantation; 1999 Mar 27; 67(6):922-8. PubMed ID: 10199745
    [Abstract] [Full Text] [Related]

  • 40. [Risk of liver failure in erythropoietic protoporphyria. Be alert for sings of cholestatic development!].
    Harper P, Thunell S, Ericzon BG, Hultcrantz R, Ros AM.
    Lakartidningen; 1998 Jun 24; 95(26-27):3051-6. PubMed ID: 9679416
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.